CHE vs JNJ · P/E 24, rev $2.53B vs P/E 17, rev $49.37B
Chemed Corp (CHE) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Chemed Corp (CHE) is a medical care facilities company listed on NYSE.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported CHE revenue for 2025-12-31 was $2.53B. Net income was $265.2M. CHE currently screens at market cap $5.79B and trailing P/E 23.8.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
CHE currently screens at market cap $5.79B and trailing P/E 23.8. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the CHE and JNJ stock pages for the full models.
Not investment advice.